TFC News
Health Canada Approves Tepezza
Health Canada approved the tepro-tumumab (Tepezza) drug for thyroid eye disease on April 17, 2025. Tepezza “reduces eye bulging and double vision…”
Call for Nominations 2025-2026
Thyroid Foundation of Canada Annual General Meeting – June 21, 2025.
The National Board is accepting nominations for positions on the Board
No Iodine in Most Processed Foods
“Iodine deficiency appears to be on the rise across North America, say researchers.” “A 2022 study out of McMaster University in Hamilton …
Regulatory Review of New TED Drug
TFC is supporting the Canadian regulatory review of the teprotumumab (Tepezza) drug for treating Thyroid Eye Disease produced by Amgen …
New Video on Hypothyroidism
The Thyroid Foundation of Canada and BGP Pharma ULC o/a Viatris Canada, have co-sponsored a new video on hypothyroidism with Dr. Sue D. Pedersen to promote public awareness.
RFA Facilities in Canada
The Thyroid Foundation of Canada is providing a list of Radio Frequency Ablation Facilities currently available in Canada for the treatment of thyroid nodules.
